NCT06864481
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Cancer Patients, +10 more
- Locations
-
- Montpellier University Hospital Montpellier, France
Clinical trial condition
Explore clinical trials studying Secondary to Immune Checkpoint Inhibitors. Study availability and eligibility vary by location and protocol.
NCT06864481